Circulating tumour DNA-guided second-line targeted therapy for patients with metastatic colorectal cancer after failure of first-line cetuximab-based treatment: A prospective, phase Ⅱ trial
ZOU J L, YANG W T,LI W H et al. Circulating tumour DNA-guided second-line targeted therapy for patients with metastatic colorectal cancer after failure of first-line cetuximab-based treatment: A prospective, phase Ⅱ trial[J]. Chin Oncol, 2026, 36(10): 1014-1025.
ZOU J L, YANG W T,LI W H et al. Circulating tumour DNA-guided second-line targeted therapy for patients with metastatic colorectal cancer after failure of first-line cetuximab-based treatment: A prospective, phase Ⅱ trial[J]. Chin Oncol, 2026, 36(10): 1014-1025.DOI: 10.19401/j.cnki.1007-3639.2026.10.004.